Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
The 3 Most Undervalued Biotech Stocks to Buy in December
Tickers INCY KNSA NBIX RHHBY
Tags Market News NBIX RHHBY
From InvestorPlace
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
Tickers PSTX RHHBF RHHBY RHHVF
Tags RHHBY why it's moving Market News
From Benzinga
Why Viking Therapeutics Was Crushing It This Week
Tickers NVO RHHBY VKTX
Tags VKTX RHHBY NVO
From Motley Fool
Altimmune’s stock pops as analysts see obesity-drug partnership potential
Tickers ALT AZN LLY NVO
Tags SPX LLY NVO
From MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
Tickers ALT JNJ LLY NVO
Tags NVO Health Care JNJ
From Benzinga
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
Tickers ALT MYNZ PFE RHHBY
Tags Penny Stocks contributors ALT
From Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
Tickers RHHBF RHHBY RHHVF
Tags General RHHVF RHHBF
From Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
Tickers LLY NVO RHHBY
Tags Market News RHHBY Jim Cramer
From Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
Tickers LLY NVO RHHBF RHHBY
Tags Benzinga Biotech Briefs
From Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
Tickers ABSI AZN NVDA RHHBY
Tags Eurasia General Media
From Benzinga
Ignore Crypto: These Stocks Could Make You Rich
Tickers MDT NEE RHHBY
Tags MDT Market News Recent Press Releases
From Motley Fool
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
Tickers CLDX LUNG PSTX RHHBY
Tags Stocks to Buy RHHBY PSTX
From InvestorPlace
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
Tickers AZN BMY MRK RHHBY
Tags Briefs Benzinga Biotech
From Benzinga
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
Tickers BIIB LLY RHHBY
Tags RHHBY BIIB Recent Press Releases
From Motley Fool
Regeneron's Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug
Tickers REGN RHHBY
Tags Health Care Earnings Large Cap
From Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
Tickers RHHBF RHHBY RHHVF SRPT
Tags Benzinga Movers Biotech
From Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
Tickers BHC CAH CVS NVS
Tags RHHBY CAH Market News
From Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Tickers LLY PFE RHHBY
Tags RHHBY PFE Market News
From Motley Fool
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
Tickers PFE RHHBY ROIV XBI
Tags Market News Recent Press Releases PFE
From Motley Fool
Why Is Roivant Sciences (ROIV) Stock Up Today?
Tickers PFE RHHBY ROIV
Tags PFE Today's Market RHHBY
From InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
Tickers PFE RHHBF RHHBY ROIV
Tags Briefs PFE Benzinga
From Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
Tickers PFE RHHBY ROIV
Tags ROIV PFE RHHBY
From MarketWatch
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
Tickers BMY BNTX PFE REGN
Tags Recent Press Releases REGN PFE
From Motley Fool
PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
Tickers PTCT RHHBY RPRX SPX
Tags RPRX SPX PTCT
From MarketWatch
Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products
Tickers RHHBF RHHBY RHHVF
Tags Benzinga Biotech Briefs
From Benzinga
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
Tickers GLUE RHHBF RHHBY RHHVF
Tags Briefs Biotech GLUE
From Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
Tickers AZN BMY MRK RHHBY
Tags Large Cap News Health Care
From Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
Tickers BMY NVO PRTA RHHBY
Tags General Rumors Briefs
From Benzinga
Tempest Therapeutics shares head back to earth after 4,000% gain
Tickers RHHBY SPX TPST
Tags RHHBY TPST SPX
From MarketWatch
TPST Stock: 7 Things to Know About Tempest Therapeutics
Tickers RHHBY TPST
Tags RHHBY TPST Today's Market
From InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.